Hypertension as a Biomarker of Efficacy in Patients With Metastatic Renal Cell Carcinoma Treated With Sunitinib
Links shared publicly online about this topic.
- 316total visits
Hypertension as a Biomarker of Efficacy in Patients With Metastatic Renal Cell Carcinoma Treated With Sunitinib
View full resource at jnci.oxfordjournals.org
Tags: Heart Disease, High Blood Pressure, Cancer, Kidney Cancer, Renal Cell Carcinoma, Kidney Health, Urinary System
Most Recently Shared on May 5, 2011 at 2:00 am By:
Hypertension as biomarker for treatment efficacy? JNCI: sunitinib data in renal cell #cancer, http://ow.ly/4Nukp, #cardiac #heart
Hypertension as a Biomarker of Efficacy in Patients With Metastatic Renal Cell Carcinoma Treated With Sunitinib - QualityPoint Technologies
qualitypointtech.net — “Hypertension may be a good thing when it comes to the treatment of metastatic RCC with sunitinib. Journal of the National Cancer Institute” View full resource at qualitypointtech.net
Most Recently Shared on July 25, 2011 at 1:45 pm By:
Hypertension as a Biomarker of Efficacy in Patients With Metastatic Renal Cell Carcinoma Treated With Sunitinib: H... http://bit.ly/qkFF7q
Cardiology Article | Biological Markers Hypertension Carcinoma, Renal Cell
mdlinx.com — “Hypertension as a biomarker of efficacy in patients with metastatic renal cell carcinoma treated with sunitinib” View full resource at mdlinx.com
Most Recently Shared on May 2, 2011 at 1:32 pm By:
Sandeep Pulim MD Doctor, Health Communicator, and Physician
Hypertension as a biomarker of efficacy in patients with metastatic renal cell carcinoma treated wit... http://bit.ly/kieB3U #cardiology
Oncology Article | Biological Markers Hypertension Carcinoma, Renal Cell
mdlinx.com — “Hypertension as a biomarker of efficacy in patients with metastatic renal cell carcinoma treated with sunitinib” View full resource at mdlinx.com
Most Recently Shared on May 2, 2011 at 12:06 pm By:
Sandeep Pulim MD Doctor, Health Communicator, and Physician
Hypertension as a biomarker of efficacy in patients with metastatic renal cell carcinoma treated with ... http://bit.ly/lsOL7M #oncology
Hypertension (HTN) as a biomarker of efficacy in patients (pts) with metastatic renal cell carcinoma (mRCC) treated with sunitinib. - ASCO
asco.org — “Hypertension (HTN) as a biomarker of efficacy in patients (pts) with metastatic renal cell carcinoma (mRCC) treated with sunitinib. - ASCO - The American Society of Clinical Oncology (ASCO) is the world's leading professional organization representing physicians who treat people with cancer. ASCO's members set the standard for patient care worldwide, and lead the fight for more effective cancer treatments, increased funding for clinical and translational research, and, ultimately, cures for the ” View full resource at asco.org
Most Recently Shared on May 4, 2010 at 12:37 pm By:
Naoto T. Ueno Oncologist, Physician, Doctor, and Internist
RT @ShinyaNakazawa: VEGF????????????????3??ASCO-GU?Cleveland Clinic?Dr Rini?VEGF????????????????????????? http://j.mp/d7u2n5 ????? #cancer
Advertisement
